HLA-DR association with the genetic susceptibility to develop ashy dermatosis in Mexican Mestizo patients

Journal of the American Academy of Dermatology

Volumn 56, Issue 4, 2007, Pages 617-620

  Correa, Marisol Carrillo ^a   Memije, Elisa Vega ^a   Vargas Alarcón, Gilberto ^d   Guzmán, Roberto Arenas ^a   Rosetti, Florencia ^b   Acuña Alonzo, Victor ^c   Martínez Rodríguez, Nonantzin ^d   Granados, Julio ^b  

^a HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c INSTITUTO NACIONAL DE ANTROPOLOGÍA E HISTORIA   (Mexico)

^d INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HLA DR ANTIGEN; HLA DR4 ANTIGEN; OLIGONUCLEOTIDE;

ADOLESCENT; ADULT; ALLELE; ARM; ARTICLE; ASHY DERMATOSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA EXTRACTION; DOT HYBRIDIZATION; ETHNIC GROUP; ETHNICITY; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC SUSCEPTIBILITY; HISPANIC; HISTOCOMPATIBILITY COMPLEX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK; SKIN DISEASE; STATISTICAL SIGNIFICANCE; TRUNK;

ADOLESCENT; ADULT; ALLELES; COHORT STUDIES; CONFIDENCE INTERVALS; ERYTHEMA; ETHNIC GROUPS; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HLA-DR4 ANTIGEN; HUMANS; MALE; MEXICO; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROBABILITY; RARE DISEASES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SKIN DISEASES;

EID: 33947123218     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.08.062     Document Type: Article

References (27)

1. Ramírez O. The ashy dermatosis (erythema dyschromicum perstans): epidemiological study and report of 139 cases. Cutis 3 (1967) 244-247
2. Arenas R. Dermatosis Cenicienta, en Dermatología Atlas Diagnóstico y tratamiento. 2nd ed. (1996), McGraw Hill Interamericana, Mexico City pp. 92-3
3. Mosher D, Fitzpatrick D. Normal skin color general considerations of pigmentary disorders. Capítulo 88. Dermatology in general medicine. 5th ed. New York: McGraw Hill; 1999. pp. 936-1017.
4. Convit J., Piquero-Martín J., and Pérez R. Erythema dyschromicum perstans. Int J Dermatol 28 (1989) 168-169
5. Novick L., and Phelps R. Erythema dyschromicum perstans. Int J Dermatol 24 (1985) 630-633
6. Knox J., Billy C., and Freeman R. Erythema dyschromicum perstans. Arch Dermatol 97 (1968) 263-272
7. Domínguez S.L., Cortés F.R., and Vega M.E. Dermatosis cenicienta. Experiencia del Departamento de Dermatología del Hospital Gea González de la ciudad de México. Arch Argent Dermatol 48 (1998) 109-113
8. Carvajal L., Uraga E., and Loayza E. Dermatitis cenicienta. Med Cutan 14 (1986) 95-99
9. Miyagawa S., Komatsu M., and Okuchi T. Erythema dyschromicum perstans immunopathologic studies. J Am Acad Dermatol 20 (1989) 882-886
10. Sánchez N., Pathak M., and Syozo S. Circumscribed dermal melaninoses: classification, light, histochemical, and electron microscopic studies on three patients with the erythema dyschromicum perstans type. Int J Dermatol 21 (1982) 25-31
11. Arbiser J., and Moschella S. Clofazimine: a review of its medical uses and mechanisms of action. J Am Acad Dermatol 32 (1995) 241-247
12. Baranda L., Torres B., and Cortés F.R. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis): the effect of clofazimine therapy. Arch Dermatol 133 (1997) 325-329
13. Vega M.E., Waxtein L., Arenas R., and Hojyo T. Ashy dermatosis and lichen planus pigmentosus: a clinicopathologic study of 31 cases. Int J Dermatol 31 (1992) 90-94
14. Vega M.E., Waxtein L., Arenas R., and Hojyo T. Ashy dermatosis versus lichen planus pigmentosus: a controversial matter. Int J Dermatol 31 (1992) 87-88
15. Berger R., Hayes T., and Dixon S. Erythema dyschromicum perstans and lichen planus: are they related?. J Am Acad Dermatol 21 (1989) 438-442
16. Leonforte J.L., and de Di Bario P. Eritema discrómico persistente versus liquen plano. Med Cutan 15 (1987) 89-92
17. Domínguez S.L., Vega M.E., and Arenas R. Dermatosis Cenicienta. Estudio clínico-patológico de veinte pacientes (1989-1990). Gac Med Mex 128 (1992) 623-628
18. Domínguez S.L., Hojyo T.T., Vega M.E., and Arenas R. Pigmentary problems in the tropics. Dermatol Clin 12 (1994) 777-784
19. Arenas R., and Bautista M. Dermatosis cenicienta. Estudio de 8 pacientes tratados con clofazimina. Rev Soc Colombiana 1 (1992) 103-105
20. Yamamoto F.J., and Granados A.J. El Complejo Mayor de Histocompatibilidad (MHC) y las enfermedades autoinmunes. Rev Colombiana Reumatol 4 (1997) 19-25
21. Woolf B. On estimating the relation between blood groups and disease. Ann Hum Genet 19 (1955) 251-253
22. Arnaiz-Villena A., Vargas-Alarcón G., Granados J., Gómez-Casado E., Longas J., Gonzales-Hevilla M., et al. HLA genes in Mexican Mazatecans, the peopling of the Americas and the uniqueness of Amerindians. Tissue Antigens 56 (2000) 405-416
23. Muro M., Marin L., Torio A., Moya-Quiles M.R., Minguela A., Rosique-Roman J., et al. HLA polymorphism in the Murcia population (Spain): in the cradle of the archaeologic Iberians. Hum Immunol 62 (2001) 910-921
24. Renquin J., Sanchez-Mazas A., Halle L., Rivalland S., Jaeger G., Mbayo K., et al. HLA class II polymorphism in Aka Pygmies and Bantu Congolese and a reassessment of HLA-DRB1 African diversity. Tissue Antigens 58 (2001) 211-222
25. Ruiz-Morales J.A., Vargas-Alarcon G., Flores-Villanueva P.O., Villareal-Garza C., Hernandez-Pacheco G., Yamamoto-Furusho J.K., et al. HLA-DRB1 allels encoding the "shared epitope" are associated with susceptibility to developing rheumatoid arthritis whereas HLA-DRB1 allels encoding an aspartic acid at position 70 of the beta-chain are protective in Mexican Mestizos. Hum Immunol 65 (2004) 262-269
26. Avila-Portillo L.M., Vargas-Alarcon G., Andrade F., Alarcon-Segovia D., and Granados J. Linkage disequilibrium of HLA-DR3 and HLA-DR4 with HLA-B alleles in Mexican patients with rheumatoid arthritis. Clin Exp Rheumatol 12 (1994) 497-502
27. Hojyo-Tomoka T., Granados J., Vargas-Alarcon G., Yamamoto-Furusho J.K., Vega-Memije E., Cortes-Franco R., et al. Further evidence of the role of HLA-DR4 in the genetic susceptibility to actinic prurigo. J Am Acad Dermatol 36 (1997) 935-937